Market Introduction
Middle East & Africa region consists of Saudi Arabia, South Africa, UAE and rest of MEA. Saudi Arabia is the largest market for blood brain barrier technologies market. Saudi Arabia's blood brain barrier technologies market is anticipated to witness a strong upsurge in the revenues during the forecast period on the back of growing healthcare awareness, rising neurodegenerative disorders. Greater awareness of health issues and increasing consumption of healthcare services sustain a substantial market for various therapies and treatments. Government of Saudi Arabia is working towards the betterment of population of the country. The improvement in the healthcare services, have increased in the last few years is from 5.9% of the government’s total budget in 2006 to 7.0% in 2014. In Saudi Arabia, increasing demand for healthcare and government initiatives favoring an increased participation from the private sector for the expansion in private sector and investors .
Countries such as UAE, and Saudi Arabia have also registered a significant number of positive patients. The COVID-19 pandemic has become the most significant challenge in the region. This challenge will be especially frightening for the region’s fragile and conflict-torn states—such as Iraq (1,963,264), Sudan (38,000), Iran (5,378,408), Israel (1,202,212) and Yemen (8,527) as it will lead to reduce imports due to disruptions in global trade, which further increases the shortages of medical supplies and other goods, resulting in a considerable price increase. The blood brain barrier technologies market in this pandemic is on rising, due to more of research about relation of blood brain barrier technologies with COVID-19 infection and its effect on the human body. Thus, pandemic has a positive impact on blood brain barrier technologies market.
Market Overview and Dynamics
The blood brain barrier technologies market in Middle East & Africa is expected to grow from US$ 196.72 million by 2028 from US$ 43.51 million in 2021. The market is estimated to grow at a CAGR of 24.1% from 2021 to 2028. Some neurologic disorders such as strokes, neuropathy, Alzheimer's disease, and Parkinson's disease are more common in the elderly, and their prevalence is increasing with higher life expectancies. According to the WHO, the population is aging rapidly worldwide. Between 2015 and 2050, the world's population over 60 years will nearly double, from 12% to 22%, and mental and neurological disorders among older adults are likely to account for 6.6% of the total disability-adjusted life year (DALYs) for this age group. Also, as per the same source, approximately 15% of adults aged 60 and over have a mental disorder. According to the CDC, Alzheimer's disease is the fifth leading cause of death in people 65 years and above. Also, the number of people living with Alzheimer's disease doubles every five years. Also the death rate due to neurological disorders is also increasing. For instance, according to the Alzheimer's Association, 1 in 3 seniors dies with Alzheimer's or dementia. Therefore, rising prevalence of age-associated neurological disorders increases the blood brain barrier technologies or better drug delivery. This factor is propelling the growth of the blood-brain barrier technologies market.
Key Market Segments
In terms of technology, the increasing permeability segment accounted for the largest share of the Middle East & Africa blood brain barrier technologies market in 2021. In terms of application, the parkinson’s disease segment accounted for the largest share of the Middle East & Africa blood brain barrier technologies market in 2021.
Major Sources and Companies Listed
A few major primary and secondary sources referred to for preparing this report on the blood brain barrier technologies market in Middle East & Africa are company websites, annual reports, financial reports, national government documents, and statistical database, among others. Major companies listed in the report are Teva Pharmaceutical Industries Ltd.; F. Hoffmann-La Roche Ltd.; Eli Lilly and Company; Bristol-Myers Squibb Company; Pfizer, Inc.; and Johnson & Johnson Services, Inc. among others.
Reasons to buy report
Middle East & Africa Blood Brain Barrier Technologies Market Segmentation
Middle East & Africa Blood Brain Barrier Technologies Market – By Technology
Middle East & Africa Blood Brain Barrier Technologies Market – By Application
Middle East & Africa Blood Brain Barrier Technologies Market – By Country
Middle East & Africa Blood Brain Barrier Technologies Market – Companies Mentioned
| Report Attribute | Details |
|---|---|
| Market size in 2021 | US$US$ 43.51 Million |
| Market Size by 2028 | US$ 196.72 Million |
| CAGR (2021 - 2028) | 24.1% |
| Historical Data | 2019-2020 |
| Forecast period | 2022-2028 |
| Segments Covered |
By Technology
|
|
Regions and Countries Covered
|
|
| Middle East and Africa | South Africa, Saudi Arabia, UAE, Rest of Middle East and Africa |
| Market leaders and key company profiles |
|
The Middle East & Africa Blood Brain Barrier Technologies Market is valued at US$US$ 43.51 Million in 2021, it is projected to reach US$ 196.72 Million by 2028.
As per our report Middle East & Africa Blood Brain Barrier Technologies Market, the market size is valued at US$US$ 43.51 Million in 2021, projecting it to reach US$ 196.72 Million by 2028. This translates to a CAGR of approximately 24.1% during the forecast period.
The Middle East & Africa Blood Brain Barrier Technologies Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Middle East & Africa Blood Brain Barrier Technologies Market report:
The Middle East & Africa Blood Brain Barrier Technologies Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Middle East & Africa Blood Brain Barrier Technologies Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Middle East & Africa Blood Brain Barrier Technologies Market value chain can benefit from the information contained in a comprehensive market report.
Please tell us your area of interest
(Market Segments/ Regions and Countries/ Companies)
E 1803, Panchshil Towers,
Wagholi, Haveli,
Pune - 412207,
Maharashtra, India
US:+1 646 791 7070
sales@businessmarketinsights.com
Get Free Sample For Middle East & Africa Blood Brain Barrier Technologies Market
